<VariationArchive VariationID="950708" VariationName="NM_000159.4(GCDH):c.860dup (p.Gly288fs)" VariationType="Duplication" Accession="VCV000950708" Version="6" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2020-07-16" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="928857" VariationID="950708">
      <GeneList>
        <Gene Symbol="GCDH" FullName="glutaryl-CoA dehydrogenase" GeneID="2639" HGNC_ID="HGNC:4189" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>19p13.13</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12891129" stop="12899999" display_start="12891129" display_stop="12899999" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13001973" stop="13010782" display_start="13001973" display_stop="13010782" Strand="+" />
          </Location>
          <OMIM>608801</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000159.4(GCDH):c.860dup (p.Gly288fs)</Name>
      <CanonicalSPDI>NC_000019.10:12896915:TT:TTT</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>19p13.13</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="19" Accession="NC_000019.10" start="12896915" stop="12896916" display_start="12896915" display_stop="12896916" variantLength="1" positionVCF="12896915" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="19" Accession="NC_000019.9" start="13007729" stop="13007730" display_start="13007729" display_stop="13007730" variantLength="1" positionVCF="13007729" referenceAlleleVCF="C" alternateAlleleVCF="CT" />
      </Location>
      <ProteinChange>G288fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.10" sequenceAccession="NC_000019" sequenceVersion="10" change="g.12896917dup" Assembly="GRCh38">
            <Expression>NC_000019.10:g.12896917dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000019.9" sequenceAccession="NC_000019" sequenceVersion="9" change="g.13007731dup" Assembly="GRCh37">
            <Expression>NC_000019.9:g.13007731dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_009292.1" sequenceAccession="NG_009292" sequenceVersion="1" change="g.10758dup">
            <Expression>NG_009292.1:g.10758dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000159.4" sequenceAccession="NM_000159" sequenceVersion="4" change="c.860dup" MANESelect="true">
            <Expression>NM_000159.4:c.860dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000150.1" sequenceAccession="NP_000150" sequenceVersion="1" change="p.Gly288fs">
            <Expression>NP_000150.1:p.Gly288fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_013976.5" sequenceAccession="NM_013976" sequenceVersion="5" change="c.860dup">
            <Expression>NM_013976.5:c.860dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_039663.1" sequenceAccession="NP_039663" sequenceVersion="1" change="p.Gly288fs">
            <Expression>NP_039663.1:p.Gly288fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_102316.1" sequenceAccession="NR_102316" sequenceVersion="1" change="n.1023dup">
            <Expression>NR_102316.1:n.1023dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_102317.1" sequenceAccession="NR_102317" sequenceVersion="1" change="n.1241dup">
            <Expression>NR_102317.1:n.1241dup</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="1970693382" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000159.4(GCDH):c.860dup (p.Gly288fs) AND Glutaric aciduria, type 1" Accession="RCV001222475" Version="5">
        <ClassifiedConditionList TraitSetID="530">
          <ClassifiedCondition DB="MedGen" ID="C0268595">Glutaric aciduria, type 1</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2019-07-19" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2019-07-19" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2020-07-16" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10699052</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">11854167</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">16602100</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="530" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2233" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Glutaric aciduria, type 1</ElementValue>
                <XRef ID="76175005" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glutaricacidemia Type 1</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glutaricaciduria, type I</ElementValue>
                <XRef ID="INHP_45_1" DB="Ege University Pediatric Genetics, Ege University" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">GA I</ElementValue>
                <XRef Type="MIM" ID="231670" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glutaryl-CoA dehydrogenase deficiency</ElementValue>
                <XRef ID="MONDO:0009281" DB="MONDO" />
                <XRef ID="360416003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Glutaric acidemia type I</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">GA 1</ElementValue>
                <XRef ID="76175005" DB="SNOMED CT" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The phenotypic spectrum of untreated glutaric acidemia type 1 (GA-1) ranges from the more common form (infantile-onset disease) to the less common form (later-onset disease â€“ i.e., after age 6 years). Of note, the GA-1 phenotype can vary widely between untreated family members with the same genotype, primarily as a function of the age at which the first acute encephalopathic crisis occurred: three months to six years in infantile-onset GA-1 and after age six years in later-onset GA-1. Characteristically these crises result in acute bilateral striatal injury and subsequent complex movement disorders. In the era of newborn screening (NBS), the prompt initiation of treatment of asymptomatic infants detected by NBS means that most individuals who would have developed manifestations of either infantile-onset or later-onset GA-1 remain asymptomatic; however, they may be at increased risk for other manifestations (e.g., renal disease) that are becoming apparent as the understanding of the natural history of treated GA-1 continues to evolve.</Attribute>
                <XRef ID="NBK546575" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6522" />
                <XRef ID="6522" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">31536184</ID>
                <ID Source="BookShelf">NBK546575</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG ACT, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-DC.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, Elevated C5-DC Acylcarnitine, Glutaric Acidemia Type I (GA I), 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/C5-DC-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Algorithm, Glutaric Acidemia Type I (GA I): Elevated C5-DC, 2022</CitationText>
              </Citation>
              <XRef ID="25" DB="Orphanet" />
              <XRef ID="C0268595" DB="MedGen" />
              <XRef ID="MONDO:0009281" DB="MONDO" />
              <XRef Type="MIM" ID="231670" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2729489" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="7133433|MedGen:C0268595" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001394574" DateUpdated="2024-02-20" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2019-07-19">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">10699052</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11854167</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">16602100</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in GCDH are known to be pathogenic (PMID: 10699052, 11854167, 16602100). This variant has not been reported in the literature in individuals with GCDH-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Gly288Argfs*55) in the GCDH gene. It is expected to result in an absent or disrupted protein product.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GCDH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000019.9:g.13007729_13007730insT</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0268595" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2729489" TraitType="Disease" MappingType="XRef" MappingValue="C0268595" MappingRef="MedGen">
        <MedGen CUI="C0268595" Name="Glutaric aciduria, type 1" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

